Ajjawi I, Rios A, Wei W, Park TS, et al. Clinical, sociodemographic, and facility-related determinants of immunotherapy use in metastatic triple-negative breast cancer. Breast Cancer Res Treat 2025 May 15. doi: 10.1007/s10549-025-07725.
PMID: 40369346